ER-Positive HER2-Negative Breast Cancer

Explore clinical trials studying ER-Positive HER2-Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

ER-Positive HER2-Negative Breast Cancer trial results

Recruiting

NCT07647328

Conditions: Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations: Research Site Duarte, California, United States

Research Site Palo Alto, California, United States

Research Site Marietta, Georgia, United States

Research Site Evanston, Illinois, United States

View all 89 locations

Active, not recruiting

NCT06590857

Conditions: Advanced Breast Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, Breast Diseases, +13 more
Locations: Research Facility Phoenix, Arizona, United States

Research Facility Irvine, California, United States

Research Facility San Diego, California, United States

Research Facility Santa Monica, California, United States

View all 31 locations

Active, not recruiting

NCT04964934

Conditions: Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations: Research Site Phoenix, Arizona, United States

Research Site Hot Springs, Arkansas, United States

Research Site Little Rock, Arkansas, United States

Research Site Long Beach, California, United States

View all 264 locations

Active, not recruiting

NCT07541703

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Medical University of Vienna, Center of Cancer Research Vienna, Austria

Active, not recruiting

NCT04711252

Conditions: Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations: Research Site Mobile, Alabama, United States

Research Site Springdale, Arkansas, United States

Research Site Harbor City, California, United States

Research Site Solvang, California, United States

View all 263 locations